Molecular Analysis of Thoracic Malignancies

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT01385722
Status
Enrolling By Invitation

Conditions

  • Carcinoma, Non-Small-Cell Lung
  • Lung Cancer
  • Mesothelioma
  • Thymic Carcinoma
  • Thymoma
  • Thymus Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

A research study to learn about the biologic features of cancer development, growth, and spread. We are studying components of blood, tumor tissue, normal tissue, and other fluids, such as urine, cerebrospinal fluid, abdominal or chest fluid in patients with cancer. Our analyses of blood, tissue, and/or fluids may lead to improved diagnosis and treatment of cancer by the identification of markers that predict clinical outcome, markers that predict response to specific therapies, and the identification of targets for new therapies.

Key Dates

Start date
Aug 31, 2011
Status verified
Dec 2025
Primary completion
Jun 30, 2031
Completion
Jun 30, 2031

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Collect detailed clinical information on patients with thoracic malignancies via the electronic medical record and a detailed patient questionnaire [ Time Frame: 20 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305-

Find similar trials in Stanford, CA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies